Effects of antipsychotic medication on electromyographic responses to transcranial magnetic stimulation of the motor cortex in schizophrenia

Journal of Neurology Neurosurgery and Psychiatry

Volumn 63, Issue 4, 1997, Pages 468-473

  Davey, Nicholas J ^a,d   Puri, Basant K ^b   Lewis, Helen S ^a   Lewis, Shon W ^c   Ellaway, Peter H ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Antipsychotic drugs; Schizophrenia; Transcranial magnetic stimulation

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROMYOGRAPHY; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; LATENT PERIOD; MALE; MOTOR CORTEX; MUSCLE ISOMETRIC CONTRACTION; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SCHIZOPHRENIA; THENAR; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 0030841566     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.63.4.468     Document Type: Article

References (22)

1. Carlsson A, Lindquist M. Effect of chlorpromazine or haloperidol on the formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 1963;20:140-4.
2. Seeman P, Lee T, Chau-Wong M, Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 1976;261:717-9.
3. Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacologic potencies of antischizophrenic drugs. Science 1976;192:481-3.
4. Pickar D, Labarca R, Linnoila M, Roy A, Hommer D, Everett D, Paul SM. Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients. Science 1984;225:954-7.
5. Hollister LE. New psychotherapeutic drugs. J Clin Psychopharm 1994;14:50-63.
6. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex [letter]. Lancet 1985;i: 1106-7.
7. Davey NJ, Romaiguère P, Maskill DW, Ellaway PH. Suppression of voluntary motor activity revealed using transcranial magnetic stimulation of the motor cortex in man. J Physiol 1994;477:223-35.
8. Rothwell JC, Thompson PD, Day BL, Boyd S, Marsden CD. Stimulation of the human motor cortex through the scalp. Exp Physiol 1991;76:159-200.
9. Puri BK, Davey NJ, Ellaway PH, Lewis SW. An investigation of motor function in schizophrenia using transcranial magnetic stimulation of the motor cortex. Br J Psychiatry 1996; 169:690-5.
10. Davey NJ, Puri BK, Lewis HS, Lewis SW, Ellaway PH. Electromyographic resonses of thenar muscles to transcrnial magnetic stimulation of the motor cortex in schizophrenic patients. J Physiol 1995;489:31P.
11. Puri BK, Davey NJ, Lewis SW. The effects of antipsychotic medication on electromyographic responses to transcranial magnetic stimulation of the motor cortex in schizophrenic patients. Schizophrenia Res 1996;18:234.
12. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994.
13. Guy W. The clinical global impression scale (CGI). In: Guy W, ed. Assessment manual for psychopharmocology. Washington, DC: US Government Printing Office, 1976. (DHEW publ No ADM-76-338.)
14. Day BL, Dressier D, Hess CW, Maertens De Noordhout A, Marsden CD, Mills K, et al. Direction of current in magnetic stimulating coils used for percutaneous activation of brain, spinal cord and peripheral nerve. J Physiol 1990;430:617.
15. Ellaway PH. Cumulative sum technique and its application to the analysis of peristimulus time histograms. Electroencephalogr Clin Neurophysiol 1978;45:302-4.
16. Baruch I, Hemsley DR, Gray JA. Differential performance of acute and chronic schizophrenics in a latent inhibition task. J Nerv Ment Dis 1988;176:598-606.
17. Ferbert A, Priori A, Rothwell JC, Day BL, Colebatch JG, Marsden CD. Interhemispheric inhibition of the human motor cortex. J Physiol 1992;453:525-46.
18. Jones EG. Varieties and distribution of non-pyramidal cells in the somatic sensory cortex of the squirrel monkey. J Comp Neurol 1975;160:205-67.
19. Fielding S, Lal H. Behavioural actions of neuroleptics. In: Iversen LL, Iversen SD, Snyder SH, eds. Handbook of psychopharmacology. Vol 10. New York: Plenum Press, 1978:91-128.
20. Haug BA, Schonle PW, Knobloch C, Kohne M. Silent period measurement revives as a valuable diagnostic tool with transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol 1992;85:158-60.
21. Priori A, Berardelli A, Inghilleri M, Accornero N, Manfredi M. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain 1994;117:317-23.
22. Ridding MC, Inzelberg R, Rothwell JC. Changes in the excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol 1995;37:181-8.